111536
论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
- 3.4 Breast Cancer (Dove Med Press)
- 3.2 Clin Epidemiol
- 2.6 Cancer Manag Res
- 2.9 Infect Drug Resist
- 3.7 Clin Interv Aging
- 5.1 Drug Des Dev Ther
- 3.1 Int J Chronic Obstr
- 6.6 Int J Nanomed
- 2.6 Int J Women's Health
- 2.9 Neuropsych Dis Treat
- 2.8 OncoTargets Ther
- 2.0 Patient Prefer Adher
- 2.2 Ther Clin Risk Manag
- 2.5 J Pain Res
- 3.0 Diabet Metab Synd Ob
- 3.2 Psychol Res Behav Ma
- 3.4 Nat Sci Sleep
- 1.8 Pharmgenomics Pers Med
- 2.0 Risk Manag Healthc Policy
- 4.1 J Inflamm Res
- 2.0 Int J Gen Med
- 3.4 J Hepatocell Carcinoma
- 3.0 J Asthma Allergy
- 2.2 Clin Cosmet Investig Dermatol
- 2.4 J Multidiscip Healthc
已发表论文
针刺联合常规药物治疗癌性骨痛的疗效和安全性：随机对照试验的网络荟萃分析
Authors Wang X, Shen Q, Hu X , Yu X , Erasmus SR, Gong L, Liu J, Fan W, Liang Y
Received 1 July 2025
Accepted for publication 9 December 2025
Published 17 December 2025 Volume 2025:18 Pages 6807—6826
DOI https://doi.org/10.2147/JPR.S550454
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Dr Houman Danesh
Xiaoying Wang,1,* Qiongying Shen,1,* Xinyi Hu,1 Xiaoshuai Yu,1 Shannah Rose Erasmus,1 Liyan Gong,2 Jianhao Liu,3 Wei Fan,3 Yi Liang1,4
1The Third Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou, Zhejiang Province, People’s Republic of China; 2Zhejiang Cancer Hospital, Hangzhou, Zhejiang Province, People’s Republic of China; 3Sanya Traditional Chinese Medicine Hospital, Sanya, Hainan Province, People’s Republic of China; 4The Third Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, Zhejiang Province, People’s Republic of China
*These authors contributed equally to this work
Correspondence: Yi Liang, The Third Clinical Medical College, Zhejiang Chinese Medical University, No. 548 Binwen Road Binjiang District, Hangzhou, Zhejiang Province, People’s Republic of China, Email liangyiwww@126.com
Background: Cancer-induced bone pain (CIBP) involves both nociceptive and neuropathic components, causing significant suffering in cancer patients. Acupuncture has shown beneficial effects on CIBP. However, given the diverse acupuncture techniques, their therapeutic efficacy may vary.
Objective: To evaluate the efficacy and safety of various acupuncture modalities integrated with conventional drug therapy for CIBP.
Methods: Randomized controlled trials (RCTs) of acupuncture combined with conventional analgesics for CIBP were searched across eight Chinese and English databases and clinical trial registries up to September 2024. Two researchers independently performed literature screening, data extraction, and bias assessment. Data were analyzed using Stata 14.0 and R 4.2.3.
Results: Twenty-two RCTs involving 1,738 patients were included, assessing techniques including manual acupuncture (MA), electroacupuncture (EA), moxibustion (MOX), acupoint injection (AI), acupoint catgut embedding (ACE), auricular-plaster therapy (AP), thumbtack needle (TN) and transcutaneous electrical acupoint stimulation (TEAS). The outcomes were assessed across 20 studies for the clinical effective rate, 13 for nausea and vomiting, and 11 for constipation.The results indicated that for the primary outcome of pain relief (as measured by clinical effective rate), TN demonstrated the highest probability of being the most effective acupuncture technique (SUCRA = 75.2%). In terms of mitigating opioid-induced adverse reactions, ACE was most effective for reducing nausea and vomiting (SUCRA = 87.7%), while EA+AP was optimal for alleviating constipation (SUCRA = 93.5%). MA+MOX achieved the best overall balance between efficacy and the incidence of adverse reactions.
Conclusion: Acupuncture combined with conventional drug therapy significantly improves pain relief in CIBP and reduces opioid-related side effects. However, due to methodological limitations and the modest sample sizes of available studies, further high-quality, multicenter trials with larger samples are needed to confirm these findings and inform clinical practice.
Keywords: cancer-induced bone pain, acupuncture, supplementary alternative therapy, network meta-analysis
1The Third Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou, Zhejiang Province, People’s Republic of China; 2Zhejiang Cancer Hospital, Hangzhou, Zhejiang Province, People’s Republic of China; 3Sanya Traditional Chinese Medicine Hospital, Sanya, Hainan Province, People’s Republic of China; 4The Third Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, Zhejiang Province, People’s Republic of China
*These authors contributed equally to this work
Correspondence: Yi Liang, The Third Clinical Medical College, Zhejiang Chinese Medical University, No. 548 Binwen Road Binjiang District, Hangzhou, Zhejiang Province, People’s Republic of China, Email liangyiwww@126.com
Background: Cancer-induced bone pain (CIBP) involves both nociceptive and neuropathic components, causing significant suffering in cancer patients. Acupuncture has shown beneficial effects on CIBP. However, given the diverse acupuncture techniques, their therapeutic efficacy may vary.
Objective: To evaluate the efficacy and safety of various acupuncture modalities integrated with conventional drug therapy for CIBP.
Methods: Randomized controlled trials (RCTs) of acupuncture combined with conventional analgesics for CIBP were searched across eight Chinese and English databases and clinical trial registries up to September 2024. Two researchers independently performed literature screening, data extraction, and bias assessment. Data were analyzed using Stata 14.0 and R 4.2.3.
Results: Twenty-two RCTs involving 1,738 patients were included, assessing techniques including manual acupuncture (MA), electroacupuncture (EA), moxibustion (MOX), acupoint injection (AI), acupoint catgut embedding (ACE), auricular-plaster therapy (AP), thumbtack needle (TN) and transcutaneous electrical acupoint stimulation (TEAS). The outcomes were assessed across 20 studies for the clinical effective rate, 13 for nausea and vomiting, and 11 for constipation.The results indicated that for the primary outcome of pain relief (as measured by clinical effective rate), TN demonstrated the highest probability of being the most effective acupuncture technique (SUCRA = 75.2%). In terms of mitigating opioid-induced adverse reactions, ACE was most effective for reducing nausea and vomiting (SUCRA = 87.7%), while EA+AP was optimal for alleviating constipation (SUCRA = 93.5%). MA+MOX achieved the best overall balance between efficacy and the incidence of adverse reactions.
Conclusion: Acupuncture combined with conventional drug therapy significantly improves pain relief in CIBP and reduces opioid-related side effects. However, due to methodological limitations and the modest sample sizes of available studies, further high-quality, multicenter trials with larger samples are needed to confirm these findings and inform clinical practice.
Keywords: cancer-induced bone pain, acupuncture, supplementary alternative therapy, network meta-analysis